Torrent Pharmaceuticals has received approval to raise funds for an amount not exceeding Rs 5,000 crore through issuance of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. The Board of Directors of the Company at its meeting held on January 27, 2020 has approved the same.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.